The NIHR Cambridge BRC is part of the NIHR and hosted by Cambridge University Hospitals NHS Foundation Trust in partnership with the University of Cambridge. We are at the heart of the Cambridge Biomedical Campus, Europe’s largest health research area.
Contact Us
Cambridge Biomedical Research Centre
Box 277
Hills Road
Cambridge
CB2 0QQ
Tel: 01223 348490
📣 The Milner Consortium Call returns with its sixth call for research proposals. Academic researchers – join our Q&A webinar to learn more and ask questions about the Call!
🗓️ 22 Jan ⏰ 10am 📍 Online
🔗 Register: https://ow.ly/5PMb50XCIuF
🔗 More info: http://www.milner.cam.ac.uk/consortiumcall/
🥳 As 2025 draws to a close, we’ve put together a snapshot of some of our key research stories over the year.
🥳 We’d like to thank everyone who took part in, or contributed to our research over 2025!
To learn more >>
@CUH_NHS @Cambridge_Uni @NIHRresearch
SMMILe enables accurate spatial quantification in digital pathology using multiple-instance learning
Common Diseases in Clinical Cohorts – Not Always What They Seem
Obesity due to MC4R deficiency is associated with reduced cholesterol, triglycerides and cardiovascular disease risk
Polygenic and developmental profiles of autism differ by age at diagnosis
Integrated omics reveals disease-associated radial glia-like cells with epigenetically dysregulated interferon response in multiple sclerosis
Clinical potential of whole-genome data linked to mortality statistics in patients with breast cancer in the UK: a retrospective analysis
Polygenic risk score for breast cancer risk prediction in Asian BRCA1 and BRCA2 pathogenic variants carriers
Identifying people with potentially undiagnosed dementia with Lewy bodies using natural language processing
The presymptomatic and early manifestations of semantic dementia
Surgery for pineal cysts with symptoms in the absence of hydrocephalus: a prospective cohort study
Reduced-energy diet in women with gestational diabetes: the dietary intervention in gestational diabetes DiGest randomized clinical trial
Glucagon Receptor Deficiency Causes Early-Onset Hepatic Steatosis
The long-term effects of chemotherapy on normal blood cells
Beta-adrenoceptor drugs and progression to Parkinson’s disease milestones in a large pooled incident cohort
Cambridge Neoadjuvant Cancer of the Prostate (CANCAP03): A Window Study into the Effects of Olaparib ± Degarelix in Primary Prostate Cancer
Neoadjuvant PARP inhibitor scheduling in BRCA1 and BRCA2 related breast cancer: PARTNER, a randomized phase II/III trial
Early childhood height, weight, and BMI development in children with monogenic obesity: a European multicentre, retrospective, observational study
A redefined indel taxonomy reveals insights into mutational signatures
Inherited predisposition to pneumothorax: Estimating the frequency of Birt-Hogg-Dubé syndrome from genomics and population cohorts
Machine Learning Achieves Pathologist-Level Celiac Disease Diagnosis